Two dozen states side with HHS in 340B dispute – Boston, Massachusetts

TDozens of states have been involved in a fierce debate between the US government and more and more pharmaceutical companies over the federal drug discount program.

of Filing In two federal courts of appeal, the state and the District of Columbia alleged that the company “ignored” its legal obligations to the 340B program. Under this program, pharmaceutical companies are required to offer discounts that are typically estimated at 25% to 50%, but can be higher. — All outpatient medicines to hospitals and clinics that primarily serve low-income patients.